584 related articles for article (PubMed ID: 19672891)
1. 25 years of HIV research! ... and what about a vaccine?
Appay V
Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
[TBL] [Abstract][Full Text] [Related]
2. Update on animal models for HIV research.
Haigwood NL
Eur J Immunol; 2009 Aug; 39(8):1994-9. PubMed ID: 19672890
[TBL] [Abstract][Full Text] [Related]
3. AIDS vaccine models: challenging challenge viruses.
Feinberg MB; Moore JP
Nat Med; 2002 Mar; 8(3):207-10. PubMed ID: 11875482
[No Abstract] [Full Text] [Related]
4. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
Bhardwaj N; Walker BD
Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
[No Abstract] [Full Text] [Related]
5. HIV-1/AIDS vaccine development: are we in the darkness.
Qiu C; Xu JQ
Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
[No Abstract] [Full Text] [Related]
6. The primate connection.
Trivedi B
Nature; 2010 Jul; 466(7304):S5. PubMed ID: 20631704
[No Abstract] [Full Text] [Related]
7. Vaccines. Monkey puzzles.
Cohen J
Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
[No Abstract] [Full Text] [Related]
8. Predictive value of primate models for AIDS.
Haigwood NL
AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
[TBL] [Abstract][Full Text] [Related]
9. T lymphocyte responses in HIV-1 infection: implications for vaccine development.
Brander C; Walker BD
Curr Opin Immunol; 1999 Aug; 11(4):451-9. PubMed ID: 10448136
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
Betts MR; Gray CM; Cox JH; Ferrari G
Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
[TBL] [Abstract][Full Text] [Related]
11. Immunization for long-term protection against AIDS using the macaque model.
Kumar A; Narayan O
Virology; 2001 Jun; 285(1):1-5. PubMed ID: 11414799
[No Abstract] [Full Text] [Related]
12. Developments in preclinical AIDS vaccine efficacy models.
Bogers WM; Cheng-Mayer C; Montelaro RC
AIDS; 2000; 14 Suppl 3():S141-51. PubMed ID: 11086857
[No Abstract] [Full Text] [Related]
13. AIDS vaccine development in primate models.
Almond NM; Heeney JL
AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
[No Abstract] [Full Text] [Related]
14. Nonhuman primate models for HIV cure research.
Apetrei C; Pandrea I; Mellors JW
PLoS Pathog; 2012; 8(8):e1002892. PubMed ID: 22956905
[No Abstract] [Full Text] [Related]
15. Towards an HIV-1 vaccine: lessons from studies in macaque models.
Hulskotte EG; Geretti AM; Osterhaus AD
Vaccine; 1998; 16(9-10):904-15. PubMed ID: 9682336
[TBL] [Abstract][Full Text] [Related]
16. Status of HIV vaccine development.
Minor JR
Am J Hosp Pharm; 1994 Jul; 51(14):1816-8. PubMed ID: 7942913
[No Abstract] [Full Text] [Related]
17. Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections.
Overbaugh J; Luciw PA; Hoover EA
AIDS; 1997; 11 Suppl A():S47-54. PubMed ID: 9451965
[No Abstract] [Full Text] [Related]
18. Chemoprophylaxis of HIV infection: moving forward with caution.
Grant RM; Wainberg MA
J Infect Dis; 2006 Oct; 194(7):874-6. PubMed ID: 16960773
[No Abstract] [Full Text] [Related]
19. Rates of HIV immune escape and reversion: implications for vaccination.
Davenport MP; Loh L; Petravic J; Kent SJ
Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
[TBL] [Abstract][Full Text] [Related]
20. Progress and obstacles in the development of an AIDS vaccine.
Letvin NL
Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
